Table 5.
Cumulative costs and benefits from the different vaccination scenario.
Vaccination | Administration costs (million $) | Effective doses (million $) | Vaccination wasted (million $) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
March | Jul | Oct | Dec | March | Jul | Oct | Dec | March | Jul | Oct | Dec | ||
SR | 40.5 | 36.7 | 37.6 | 39.0 | 21.7 | 18.4 | 19.1 | 20.4 | 18.8 | 18.3 | 18.5 | 18.6 | |
ST | 16.9 | 13.1 | 13.4 | 14.9 | 14.3 | 9.7 | 10.6 | 12.5 | 2.6 | 3.4 | 2.8 | 2.4 | |
SM | 27.6 | 23.7 | 24.1 | 25.6 | 18.1 | 14.1 | 14.8 | 16.5 | 9.5 | 9.6 | 9.3 | 9.1 | |
GSCE | 27.3 | 23.7 | 24.1 | 25.5 | 18.9 | 15.0 | 15.9 | 17.5 | 8.4 | 8.7 | 8.2 | 8.0 | |
Benefits | BS (million $) | BM (million $) | BT = BS + BM (million $) (BCR = BT/cost) | ||||||||||
March | Jul | Oct | Dec | March | Jul | Oct | Dec | March | Jul | Oct | Dec | ||
SR | 264 | 166 | 171 | 211 | 25.5 | 18.5 | 19.3 | 22.1 | 289.9 (7.15) | 184.5 (5.0) | 190.3 (5.1) | 231.1 (5.9) | |
ST | 378 | 235 | 240 | 337 | 38.7 | 24.3 | 29.9 | 34.9 | 416.7 (24.6) | 259.3 (19.4) | 269.9 (20.1) | 371.9 (24.9) | |
SM | 326 | 212 | 240 | 284 | 32.7 | 22.7 | 25.8 | 29.5 | 358.7 (12.9) | 234.7 (9.9) | 265.8 (11.02) | 313.5 (12.2) | |
GSCE | 387 | 276 | 314 | 354 | 40.0 | 29.4 | 33.3 | 37.2 | 427 (15.6) | 305.4 (12.9) | 347.3 (14.4) | 391.2 (15.3) |
SR, National Strategy; ST, Targeted scenario; SM, Mixed scenario (SM) and GSCE, Global Strategy for Control and Eradication. Top part of the table Vaccination information; bottom part benefits. Administration Costs indicate the total amount spent between 2018–2030, while Vaccination Wasted indicates the cost of the vaccine given to already vaccinated or immunized animals, with Effective doses we indicated the total costs of vaccinating only susceptible animals. Benefits are classified as those related to the market value of the animals (BS) and those related to the avoidance of medical treatments (BM). BT indicates the total benefit as the sum of the previous ones. Bold cells indicate those strategies with highest Benefit cost ratio (in parenthesis).